Skip to main content
logo
Kane Biotech Inc. (TSXV:KNE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
May 1, 2026, 3:15 PM EST

Kane Biotech Revenue

In the year 2025, Kane Biotech had annual revenue of 427.87K CAD, down -79.44%. Kane Biotech had revenue of -21.14K in the quarter ending December 31, 2025.

Revenue
427.87K
Revenue Growth
-79.44%
P/S Ratio
14.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.87K-1.65M-79.44%
Dec 31, 20242.08M1.93M1,296.75%
Dec 31, 2023148.98K-2.52M-94.42%
Dec 31, 20222.67M1.06M65.96%
Dec 31, 20211.61M266.21K19.84%
Dec 31, 20201.34M-351.95K-20.78%
Dec 31, 20191.69M1.19M234.51%
Dec 31, 2018506.27K85.80K20.41%
Dec 31, 2017420.47K298.90K245.87%
Dec 31, 2015121.57K--
Dec 31, 2014---
Dec 31, 2013159.95K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Kane Biotech News

More News